Dr. Eric C. Feliberti
Schedule a Conversation with a HIPEC Surgeon
The surgeon or staff member will make their best effort to call you at your requested time. If they become unavailable you will receive a text.
Board certification by an ABMS Member Board is the premier, independently assessed credential attainable in medicine today.
City of Hope National Medical Center in Duarte, CA
Dr. Feliberti received his medical degree at the University of Texas Medical Branch in Galveston, Texas where he also completed a general surgery internship and residency. He completed a surgery oncology fellowship at The City of Hope National Medical Center in Durante, California. Dr. Feliberti is board certified by the American Board of Surgery-Surgery.
Born the last of four children in New Orleans, Dr. Feliberti grew up in El Paso, TX. He received his B.A. from Cornell University cum laude and distinction in all subjects. He matriculated to the University of Texas Medical Branch in Galveston, TX for medical school, where he also completed a general surgery residency. He completed a surgical oncology fellowship at the City of Hope National Medical Center in Duarte, CA.
Dr. Feliberti joined the faculty at Eastern Virginia Medical School in Norfolk, VA now as an associate professor and attained fellowship in the American College of Surgeons. Dr. Feliberti serves as the chairman of the cancer committee as well as the director of the breast center at Sentara Norfolk General Hospital. He also is the medical director for the Breast Evaluation Program, a clinic for uninsured women to be evaluated for breast cancer. Dr. Feliberti facilitates the clinical trials program at Sentara Norfolk General Hospital as the site principal investigator for the Alliance for Clinical Trials in Oncology and is the Associate Director of Clinical Cancer Research at the Leroy T. Canoles, Jr., Cancer Research Center. He maintains an interest in breast cancer disparities, minimally invasive cancer surgery, gastroenteropancreatic endocrine tumors and peritoneal surface malignancies.